NeuroMetrix, Inc. Common Stock
NURO
NURO was delisted on the 1st of May, 2025.
7 hedge funds and large institutions have $371K invested in NeuroMetrix, Inc. Common Stock in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 4 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
22% less funds holding
Funds holding: 9 → 7 (-2)
26% less capital invested
Capital invested by funds: $500K → $371K (-$129K)
50% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Bank of New York Mellon
New York
|
+$101K |
| 2 |
Renaissance Technologies
New York
|
+$83.8K |
| 3 |
Goldman Sachs
New York
|
+$62.4K |
| 4 |
Morgan Stanley
New York
|
+$45.3K |
| 5 |
VKH
Virtu KCG Holdings
New York
|
+$34.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$187K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$20K |
| 3 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$12K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$8K |
| 5 |
BlackRock
New York
|
-$3.72K |
NURO Hedge Fund Activity: Q2 2017 in Review
7 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in NeuroMetrix, Inc. Common Stock (NURO) for Q2 2017, worth a combined $371K — down 26% from $500K a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of NURO and 2 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 4 added.
The largest buyer was Bank of New York Mellon, adding an estimated $101K. The largest seller was Sabby Management, exiting entirely with an estimated $187K sold.
- 7 institutional investors held NeuroMetrix, Inc. Common Stock (NURO) as of Q2 2017, down from 9 in Q1 2017.
- Funds reported $371K of NeuroMetrix, Inc. Common Stock stock for Q2 2017, down 26% quarter-over-quarter.
- 2 funds opened new NeuroMetrix, Inc. Common Stock positions in Q2 2017 and 4 closed out, a net change of -2 holders.
- The largest NeuroMetrix, Inc. Common Stock buyer in Q2 2017 was Bank of New York Mellon, an estimated $101K added.
- The largest NeuroMetrix, Inc. Common Stock seller in Q2 2017 was Sabby Management, an estimated $187K sold.
Based on aggregated 13F filings for Q2 2017.